Reverse kidney damage: A breakthrough treatment that may transform kidney treatment

A groundbreaking discovery offers hope for reversing kidney damage, challenging the notion that it’s irreversible. Researchers found that blocking ceramides, fat linked to kidney cell injury, protected and restored normal function in animal trials. This breakthrough could shift kidney disease treatment from slowing decline to actively restoring health, potentially reducing the need for dialysis and transplantation.

Kidney disease has long been considered a progressive and irreversible condition, where treatment focuses only on slowing decline rather than restoring lost function. However,  a promising scientific discovery challenges that belief. Researchers have identified a potential way to reverse kidney damage by blocking the activity of ceramides, a type of  fat molecule kinked to cellular injury inside the kidney. In animal trials, targeting ceramides protected kidney cells from damage entirely and allowed renal function to return to normal. In future studies confirms similar results in humans, this breakthrough could transform how kidney disease is treated and provide new hope for millions of patients worldwide.

A peer-reviewed study published in JCI Insight investigated the role of ceramides in acute kidney injury. The researchers demonstrated that suppressing ceramides production in mice preserved mitochondrial function in kidney cells and prevented injury. They reported significantly improved kidney structure and function in treated animals/

How the potential to reverse kidney damage could change future treatment

The role of ceramides in kidney injury

Ceramides are lipid molecules that rise sharply in kidney tissue when the organs are under stress.

High ceramide levels interfere with mitochondrial function inside kidney cells.  Mitochondria provide the energy cells need to survive and recover, so once they fail, cells begin to die. This leads to inflammation, scarring and long-term loss of kidney function. Researchers believe that stopping ceramide accumulation may prevent early injury from becoming permanent damage.

Protecting kidney cells by reducing ceramides

In the recent animal study, scientists treated mice with a compound that reduced ceramide production before inducing acute kidney injury. The treated mice maintained healthy mitochondrial function and experienced no significant loss of kidney performance. In contrast, untreated mice developed severe damage typical of acute kidney injury. This suggests that kidney cells may be able to recover if they are protected at the cellular level.

Why this matters for patient care

If treatments based on ceramide control can be proven safe and effective in humans, the implications are significant. Instead of waiting for damage to accumulate and eventually relying on dialysis or transplantation, patients may one day receive targeted therapy to restore healthy kidney function shortly after injury. This could dramatically change clinical outcomes for individuals affected by sudden kidney failure caused by infection, surgery complications or medication side effects.

What reversing kidney damage could mean for patients

Hope for recovery after acute kidney injury rather than long-term decline.

Less progression to chronic kidney disease and fewer cases of end-stage kidney failure.

Reduced need for dialysis or kidney transplantation.

Improved quality of life and reduced healthcare burden.

Earlier intervention guided by future biomarkers, like urinary ceramide levels.

Why caution and further research are essential

Although results are promising, research is still in early stages. The treatment has only been tested in mice and human kidneys may respond differently. The studies also examined injury prevention rather than full reversal of long-standing kidney damage. Clinical trials will need to confirm safety, dosage, and effectiveness, in humans, and it remains unclear how well this method might work for chronic kidney disease with established scarring.

What scientists plan to explore next

Research groups are now preparing to test ceramic-targeting drugs in human cell models and later. Early-stage clinical trials. Scientists are also exploring whether combining metabolic therapies, cell regeneration strategies and anti-fibrosis treatments could enhance kidney repair even further. Another focus is the development of early detection tools, so patients receive support before irreversible scarring forms.

The discovery that kidney function can be restored in animal studies challenges one of the longest-held assumption in nephrology. If researchers succeed in translating these findings to human treatment, the future of kidney care may shift from slowing damage to restoring health. Though there is a long road ahead, the progress already achieved marks an important step toward a future where kidney damage does not have to be permanent.

 

 

This is only for your information, kindly take the advice of your doctor for medicines, exercises and so on.   

https://gscrochetdesigns.blogspot.com. one can see my crochet creations  

https://gseasyrecipes.blogspot.com. feel free to view for easy, simple and healthy recipes    

https://kneereplacement-stickclub.blogspot.com. for info on knee replacement

https://GSiyers home remedies.blogspot.com   is the latest addition to my blogs

A groundbreaking discovery offers hope for reversing kidney  ..

Read more at:
http://timesofindia.indiatimes.com/articleshow/125792760.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

Tamil Nadu’s special protein-rich diet for dialysis patients: Why it is essential

   

Recently, the Tamil Nadu Health Department launched a new protein-rich diet scheme in all government hospitals to improve the health of dialysis patients.

Under this plan, launched by Health and Family Welfare Minister Ma Subramanian on 19 June, people undergoing dialysis will receive a special meal during each session, including milk, boiled eggs, chickpeas and low-salt biscuits, to help replace the protein they lose during treatment.

Experts say this is a much-needed step. Dialysis removes not only waste from the blood but also important nutrients, such as protein, especially albumin. Without enough protein, patients may face muscle loss, tiredness, and low immunity.

But how effective is this new diet? Why is a protein-rich diet important for dialysis patients? And what common food myths are still misleading patients?

Why protein is essential

“Many dialysis patients don’t get enough protein, and that leads to serious weakness,” said Dr Sundar Sankaran, Director of the Aster Institute of Renal Transplantation.

“Protein is needed to build muscle, fight infections, and repair tissues. Without enough, the body breaks down its muscle,” he explained. The result is protein-energy wasting (PEW), a condition that causes muscle loss, poor wound healing, frequent infections, and low blood pressure.

“People with mild kidney failure restrict too much protein and end up becoming weak,” he said. He explained that this fear-driven restriction is often based on outdated or Western guidelines. “The protein restriction is for Western diets, not for Indian, especially South Indian vegetarian diets, which are already low in protein,” he added.

He warned that low albumin levels combined with low creatinine in dialysis patients is a sign of severe protein deficiency. “This situation needs the attention of a nephrologist and a renal dietitian right away,” he said. For a 60 kg patient, the daily protein requirement is around 72–90 grams, but many patients eat far less than that, either because they’re unaware or they fear worsening their kidney condition. “That fear is based on myths,” he added. 

He noted that the government’s protein diet package is a helpful step, especially for low-income patients.

“However, it provides only about 20 to 30 percent of a dialysis patient’s daily protein needs. It’s a supplement, not a complete solution,” said Dr Sankaran.

Noting patients still need to eat other protein-rich foods like lentils, paneer, fish, or lean chicken to meet their full requirement, he added that Tamil Nadu is the only state doing this so far: “It’s a good beginning for others to follow and do even better.”

Busting myths and mistakes 

While stressing the importance of protein intake, Dr Sankaran also warned about common mistakes and myths that mislead many patients. “High potassium is the real killer in dialysis,” he said. Eating too many bananas, oranges, or tomatoes can lead to dangerous potassium buildup. 

Fluid control is also important. “Kidneys in these patients can’t remove extra fluids. They need to be careful with water, tea, coffee and soup, especially in hot, humid weather when they feel thirsty.” He also advised caution with supplements, “Don’t use protein powders or herbal products without medical advice. It can create more problems.”

There are also several myths that confuse patients, he said. “One of the most common is that ‘all protein is bad for kidneys’. In fact, dialysis patients need more protein, not less. Another harmful belief is that ‘drinking more water helps flush the kidneys’. For dialysis patients, too much fluid can be dangerous. Many also think pink salt is safer, but sodium-free salts like pink salt contain potassium, which can be fatal if levels go up,” he warned. 

For families trying to plan meals at home, he suggested using affordable protein sources like lentils, soaked chickpeas, eggs, and small amounts of paneer or fish. Combining foods like rice with dal can help meet protein needs. “Plant proteins can be enough if planned well, but adding milk or eggs improves quality,” he said. 

For rural and low-income families, using local grains, vegetables, and support from government programmes can help. He also warned that eating too much protein without medical advice can be risky. “Excess protein may lead to high urea, phosphate overload, and fluid imbalance,” he said. “It’s important to get the amount right, not too little, not too much.” 

However, above all, he stressed, “Don’t follow online kidney diets blindly, which is completely based on the concept of ‘One-size-fits-all’. Every patient’s needs are different and so the diet plan needs personalization. Always take help from a renal dietitian.”

In an age of social media myths and half-truths, doctors say it’s more important than ever for dialysis patients to follow a proper, protein-rich diet guided by real medical advice.

General diet plan and the need for personalisation

Deepshikha Khattar, a renal dietitian at Dr RML Hospital in New Delhi, shared a general diet plan that could support dialysis patients in maintaining their nutritional balance.

She stressed that while protein is crucial to compensate for the loss during dialysis, it should be consumed in moderation, as excess protein, especially from vegetarian sources, can lead to high phosphorus levels, which are harmful to kidney patients.

On a typical day, patients can start their morning with a cup of toned milk (without sugar) and a few plain biscuits. For breakfast, they may have two rotis or a bowl of poha (beaten rice), daliya (broken wheat), or sabudana-based (sago) dishes, along with curd or milk, a little paneer, and egg white, if allowed. Fruit from the safe list, such as apple, papaya, guava, or pear, can be taken mid-morning.

Lunch could include two rotis or a small bowl of rice, one bowl of cooked vegetables, a portion of salad, and a protein source like paneer, chicken, curd, or pulses. In the evening, tea can be taken with light snacks such as puffed rice, makhana, or biscuits. Dinner can be similar to lunch, with rotis or sabudana khichdi, vegetables, salad, and pulses. A small bowl of milk or kheer made from sabudana or makhana can be consumed after dinner.

She also advised patients to limit their fluid intake and avoid high-potassium and high-phosphorus foods like red meat, egg yolk, rajma, soybean, full-cream milk, and certain fruits and vegetables. Vegetables like cabbage, cauliflower, and potatoes can be eaten after cutting them into small pieces and boiling them briefly to reduce potassium content.

While general diet plans can be useful, a personalised diet is essential for dialysis patients due to their specific medical needs. Deepshikha explained that key nutrients like protein, potassium, phosphorus and sodium must be carefully balanced based on the patient’s medical reports.

“For example, if a person weighs 60 kg, they may need around 1.2 to 1.5 grams of protein per kg per day. But if we increase protein, especially in vegetarian diets, phosphorus levels also go up, which can be harmful for dialysis patients,” she said.

This delicate balance makes personalised guidance crucial. She added that phosphorus-rich foods like milk and other vegetarian sources can complicate the diet. “Sometimes we suggest protein powders to maintain protein intake without pushing up phosphorus levels”.

Hence, even though a general plan offers a basic structure, the safest and most effective approach is to consult a renal dietitian for a plan tailored to each patient’s condition.

 

This is only for your information, kindly take the advice of your doctor for medicines, exercises and so on.   

https://gscrochetdesigns.blogspot.com. one can see my crochet creations  
https://gseasyrecipes.blogspot.com. feel free to view for easy, simple and healthy recipes    
https://kneereplacement-stickclub.blogspot.com. for info on knee replacement
https://GSiyers home remedies.blogspot.com   is the latest addition to my blogs

 

Rapid Blood Test Identifies COVID-19 Patients at High Risk of Severe Disease

One of the most vexing aspects of the COVID-19 pandemic is doctors' inability to predict which newly hospitalized patients will go on to develop severe disease, including complications that require the insertion of a breathing tube, kidney dialysis or other intensive care. Knowledge of a patient's age and underlying medical conditions can help predict such outcomes, but there are still surprises when younger, seemingly healthier patients suffer severe complications that can lead to death.

Now, scientists at Washington University School of Medicine in St. Louis have shown that a relatively simple and rapid blood test can predict -- within a day of a hospital admission -- which patients with COVID-19 are at highest risk of severe complications or death.

The study, published Jan. 14 in JCI Insight, involved nearly 100 patients newly admitted to the hospital with COVID-19.

The blood test measures levels of mitochondrial DNA, a unique type of DNA molecule that normally resides inside the energy factories of cells. Mitochondrial DNA spilling out of cells and into the bloodstream is a sign that a particular type of violent cell death is taking place in the body.

"Doctors need better tools to evaluate the status of COVID-19 patients as early as possible because many of the treatments -- such as monoclonal antibodies -- are in short supply, and we know that some patients will get better without intensive treatments," said co-senior author Andrew E. Gelman, PhD, the Jacqueline G. and William E. Maritz Endowed Chair in Immunology and Oncology in the Department of Surgery.

"There's so much we still don't understand about this disease," he added. "In particular, we need to understand why some patients, irrespective of their ages or underlying health in some cases, go into this hyperinflammatory death spiral. Our study suggests that tissue damage may be one cause of this spiral, since the mitochondrial DNA that is released is itself an inflammatory molecule."

The researchers said the test could serve as a way to predict disease severity as well as a tool to better design clinical trials, identifying patients who might, for example, benefit from specific investigational treatments. They also said they would like to evaluate whether the test could serve as a way to monitor the effectiveness of new therapies. Presumably, effective treatments would lower mitochondrial DNA levels.

"We will need larger trials to verify what we found in this study, but if we could determine in the first 24 hours of admission whether a patient is likely to need dialysis or intubation or medication to keep their blood pressure from dropping too low, that would change how we triage the patient, and it might change how we manage them much earlier in the disease course," said co-senior author Hrishikesh S. Kulkarni, MD, an assistant professor of medicine.

The researchers, including co-first authors Davide Scozzi, MD, PhD, a staff scientist, and Marlene Cano, PhD, a postdoctoral research scholar, evaluated 97 patients with COVID-19 at Barnes-Jewish Hospital, measuring their mitochondrial DNA levels on the first day of their hospital stays. They found that mitochondrial DNA levels were much higher in patients who eventually were admitted to the ICU, intubated or died. The researchers found this association held independently of a patient's age, sex and underlying health conditions.

On average, mitochondrial DNA levels were about tenfold higher in patients with COVID-19 who developed severe lung dysfunction or eventually died. Those with elevated levels were almost six times more likely to be intubated, three times more likely to be admitted to the ICU and almost twice as likely to die compared with those with lower levels.

Further, the test predicted outcomes as well as or better than existing markers of inflammation currently measured in patients hospitalized with COVID-19. Most other markers of inflammation measured in patients with COVID-19, including those still under investigation, are general markers of systemic inflammation, rather than inflammation specific to cell death, according to the researchers.

"Viruses can cause a type of tissue damage called necrosis that is a violent, inflammatory response to the infection," Gelman said. "The cell breaks open, releasing the contents, including mitochondrial DNA, which itself drives inflammation. In COVID-19 patients, there has been anecdotal evidence of this type of cell and tissue damage in the lung, heart and kidney. We think it's possible that measures of mitochondrial DNA in the blood may be an early sign of this type of cell death in vital organs."

The researchers also emphasized that the test is quick and straightforward to perform in most hospital settings because it uses the same machinery that processes the standard PCR test for COVID-19. The method they developed allows mitochondrial DNA levels to be quantified directly in the blood. Without requiring intermediate steps to extract the DNA from the blood, the technique returned results in less than an hour.

Before they can apply for approval from the Food and Drug Administration (FDA), the scientists will need to verify that the test is accurate in a larger multi-center trial. They have plans to expand the research to more sites.

The study utilized samples obtained from the School of Medicine's COVID-19 biorepository, which was developed by co-authors Jane O'Halloran, MD, PhD, an assistant professor of medicine; Charles Goss, PhD, an instructor in biostatistics; and Phillip Mudd, MD, PhD, an assistant professor of emergency medicine.
 

 This is only for your information, kindly take the advice of your doctor for medicines, exercises and so on.     

https://gscrochetdesigns.blogspot.com. one can see my crochet creations  
https://gseasyrecipes.blogspot.com. feel free to view for easy, simple and healthy recipes    
https://kneereplacement-stickclub.blogspot.com. for info on knee replacement